Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.49 |
| ▸ | GBA1 | P04062 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | TEAD1 | P28347 | 2/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8227791 | 1.00 | HTR2C (0.49) | HTR2CGBA1SLC6A2SLC6A4TEAD1 | |
| Hydrochloric Acid SCHEMBL23632761 | 0.98 | HTR2C (0.50) | HTR2CGBA1SLC6A2SLC6A4TEAD1 | |
| Oxalic Acid SCHEMBL1760951 | 0.91 | SLC6A2 (0.44) | HTR2CGBA1SLC6A2SLC6A4 | |
| SCHEMBL27644931 | 0.90 | EED (0.48) | HTR2CSLC6A2SLC6A4TEAD1HRH4 | |
| SCHEMBL13576641 | 0.90 | EED (0.48) | HTR2CSLC6A2SLC6A4TEAD1HRH4 | |
| Acetic Acid SCHEMBL1812749 | 0.90 | SLC6A4 (0.46) | HTR2CGBA1SLC6A2SLC6A4 | |
| SCHEMBL894468 | 0.90 | GBA1 (0.59) | HTR2CGBA1SLC6A2SLC6A4TEAD1 | |
| Hydrochloric Acid SCHEMBL4773715 | 0.88 | GBA1 (0.58) | HTR2CGBA1SLC6A2SLC6A4TEAD1 | |
| SCHEMBL22462798 | 0.86 | CHRNB2 (0.43) | HTR2CSLC6A2SLC6A4TEAD1 | |
| Hydrochloric Acid SCHEMBL22462991 | 0.83 | GBA1 (0.51) | HTR2CGBA1SLC6A2SLC6A4TEAD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114174280-A | Substituted aminotriazoles useful as chitinase inhibitors | 昂科艾伦迪治疗法公司 | 2022-03-11 | — | — | CN | disclosed |